Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-09-11

FDA Approved: POTASSIUM PHOSPHATES — Original Application (Hospira, Inc.)

View source ↗

Summary

FDA approved Hospira's Potassium Phosphates as an original generic product (ANDA 217459). It is indicated to treat phosphate deficiency (hypophosphatemia) in pa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • POTASSIUM PHOSPHATES (POTASSIUM PHOSPHATES IN SODIUM CHLORIDE)

Snippet

ORIG AP for POTASSIUM PHOSPHATES (POTASSIUM PHOSPHATES)